98%
921
2 minutes
20
Background: Evidence has demonstrated that patients with obesity exhibited cognitive impairment and cerebral damage. Bariatric surgery is an effective intervention for obesity and is associated with cognitive improvement. However, the underlying mechanisms by which bariatric surgery improves cognitive function remain unclear. This study aimed to evaluate cognitive alterations in patients with obesity before and after bariatric surgery, and to further explore the associations among fat reduction, cognitive alterations, and underlying cerebral changes.
Methods: We conducted an exploratory study on 23 patients with obesity who underwent bariatric surgery. These patients received anthropometric measurements, detailed cognitive assessments, and functional magnetic resonance imaging (fMRI) scans at baseline and 12 months post-surgery to evaluate neuroimaging and cognitive changes.
Results: Compared to baseline, patients with obesity exhibited significant improvements in immediate and delayed memory following bariatric surgery. fMRI scans also revealed increased left hippocampal volume and enhanced right hippocampal activation in patients with obesity postoperatively. Furthermore, these improvements in cognitive function and hippocampal activation were associated with reductions in visceral fat (β = -0.122, 95% bootstrap CI: -0.210, -0.030) and hepatic steatosis (β = -0.147, 95% bootstrap CI: -0.266, -0.053) in the mediation analysis.
Conclusion: This study showed that bariatric surgery significantly reduced fat deposition and improved cognitive function in patients with obesity. Importantly, the improvement in brain functional activation played a key role in alleviating cognitive impairment, underscoring its vital importance in cognitive health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11695-025-07964-9 | DOI Listing |
J Obes Metab Syndr
September 2025
Integrated Perioperative Geriatric Excellent Research Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: Morbid obesity is a well-established risk factor for cardiovascular disease. Diastolic dysfunction, particularly in non-cardiac surgeries, has been associated with increased incidence of adverse cardiovascular events. This study aimed to evaluate the prevalence of diastolic dysfunction in morbidly obese patients undergoing bariatric surgery and to identify associated clinical risk factors using transesophageal echocardiography (TEE).
View Article and Find Full Text PDFDiabetes Res Clin Pract
September 2025
Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address:
Obes Surg
September 2025
Department of Nephrology, Xinqiao Hospital, Army Medical University, Chongqing, China.
Obes Surg
September 2025
Department of Medical and Surgical Sciences, Internal Medicine Unit, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Obesity is a globally prevalent condition associated with elevated morbidity and mortality. Metabolic and bariatric surgery offers a definitive treatment for class III (BMI > 40) obesity, achieving substantial, enduring weight loss and improving metabolic health. Despite extensive research on the physical benefits, comparatively fewer reviews investigate the psychosocial and relational changes accompanying these procedures.
View Article and Find Full Text PDFObes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDF